Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  INDONESIA STOCK EXCHANGE  >  PT Darya-Varia Laboratoria Tbk    DVLA   ID1000117203

PT DARYA-VARIA LABORATORIA TBK

(DVLA)
  Report
End-of-day quote. End-of-day quote INDONESIA STOCK EXCHANGE - 11/26
2550 IDR   0.00%
 SummaryChartsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Indonesia Stock Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
2580 2590 2550 2550 2550 Last
37700 52700 56900 23400 27300 Volume
0.00% +0.39% -1.54% 0.00% 0.00% Change
Financials
Sales 2018 1 700 B 121 M 121 M
Net income 2018 201 B 14,2 M 14,2 M
Net cash position 2018 306 B 21,7 M 21,7 M
P/E ratio 2018 10,8x
Yield 2018 5,52%
Sales 2019 1 813 B 129 M 129 M
Net income 2019 222 B 15,7 M 15,7 M
Net cash position 2019 339 B 24,1 M 24,1 M
P/E ratio 2019 11,3x
Yield 2019 4,76%
Capitalization 2 856 B 202 M 203 M
EV / Sales 2018 1,09x
EV / Sales 2019 1,20x
Nbr of Employees 1 252
Free-Float 7,87%
More Financials
Company
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is an Indonesia-based company operating in the pharmaceutical industry. The Company's major business activities are classified into three business segments: Prescription drugs, Consumer health products and Export and toll manufacturing services. Darya-Varia's leading products under the Prescription drugs segment are namely Mediamer B6 and Obimin - AF, drugs under woman... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
More about the company
All news about PT DARYA-VARIA LABORATORIA TBK

- No features available -

More news
News in other languages on PT DARYA-VARIA LABORATORIA TBK

- No features available -

More news
Chart PT DARYA-VARIA LABORATORIA TBK
Duration : Period :
PT Darya-Varia Laboratoria Tbk Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Marlia Hayati Goestam President Director
Clinton Andrew Campos Hess President Commissioner
Andre Rajagukguk Finance Director
Angelito Celso Corcame Racho Head-Operating Manufacturing, R&D
Bobby Gulliano Head-Information & Communication Systems
Sector and Competitors
1st jan.Capitalization (M$)
PT DARYA-VARIA LABORATORIA TBK13.33%202
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-3.47%285 939
NOVARTIS AG-11.58%203 854
PFIZER INC.-1.59%203 048
MERCK & CO., INC.-11.97%202 555